We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc. (HIMS)'s share was trading at $27.60 as of Nov 13th. HIMS’s trailing and forward P/E were 62.73 and 64.10 respectively according to Yahoo Finance.
[caption id="attachment_1206779" align="aligncenter" width="768"]HIMS, founded in 2017 by Andrew Dudum, aims to revolutionize healthcare...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.